Gastrointestinal Cancer Markers

1982 ◽  
pp. 105-132 ◽  
Author(s):  
Hans O. Sjögren ◽  
Britta Wahren
Keyword(s):  
Gastrointestinal Cancer ◽  
Cancer Markers

Proteomic analysis of urinary upper gastrointestinal cancer markers

2011 ◽  
Vol 5 (5-6) ◽  
pp. 289-299 ◽  
Author(s):  
Holger Husi ◽  
Nathan Stephens ◽  
Andrew Cronshaw ◽  
Alisdair MacDonald ◽  
Iain Gallagher ◽  
...  
Keyword(s):  
Gastrointestinal Cancer ◽  
Proteomic Analysis ◽  
Cancer Markers ◽  
Upper Gastrointestinal Cancer ◽  
Upper Gastrointestinal

Expression of splice variants; The human cholecystokinin-B receptor in association with gastrointestinal cancer

2001 ◽  
Vol 120 (5) ◽  
pp. A507-A507
Author(s):  
D KANG ◽  
Y WHANG ◽  
J YOO ◽  
I SONG ◽  
J OH ◽  
...  
Keyword(s):  
Gastrointestinal Cancer ◽  
Splice Variants

CD9 negatively regulates growth signaling of the gastrointestinal cancer cells

2001 ◽  
Vol 120 (5) ◽  
pp. A660-A660
Author(s):  
Y MURAYAMA ◽  
Y SHINOMURA ◽  
J MIYAGAWA ◽  
H YOSHIDA ◽  
T KIYOHARA ◽  
...  
Keyword(s):  
Cancer Cells ◽  
Gastrointestinal Cancer

The Gastrointestinal Cancer Committee of the National Advisory Cancer Council

1955 ◽  
Vol 29 (4) ◽  
pp. 492-493
Author(s):  
George T. Pack ◽  
Morris K. Barrett
Keyword(s):  
Gastrointestinal Cancer ◽  
Cancer Council

Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer

2020 ◽  
Author(s):  
S Leyvraz ◽  
J Berlin ◽  
DS Hong ◽  
J Deeken ◽  
V Boni ◽  
...  
Keyword(s):  
Gastrointestinal Cancer ◽  
Efficacy And Safety

Surgery and metastases of stomach cancer in liver

2020 ◽  
pp. 21-24
Author(s):  
F. M. Dzhuraev ◽  
S. L. Gutorov ◽  
E. I. Borisova ◽  
G. G. Khakimova
Keyword(s):  
Gastric Cancer ◽  
Liver Metastases ◽  
Lymphovascular Invasion ◽  
Peritoneal Dissemination ◽  
Surgical Removal ◽  
Relapse Free Survival ◽  
Cancer Markers ◽  
Free Survival ◽  
The Poor ◽  
Isolated Liver

Liver metastases of gastric cancer determine the poor prognosis. Until now The expediency of their surgical removal has been controversial. However, according to a number of studies, the removal of potentially operable isolated liver metastases allows a significant increase of overall and relapse-free survival in some cases. The review is dedicated to the analysis of prognostic factors that allow selecting patients for surgical removal of liver metastases of gastric cancer. The main criteria are: effective perioperative chemotherapy; stage under T4, N0, absence of lymphovascular invasion, absence of peritoneal dissemination, number less than 3, size up to 4 cm, localization of metastases in one lobe, low level of cancer markers CA 19-9 and CEA.

Major Hereditary Gastrointestinal Cancer Syndromes: a Narrative Review

2017 ◽  
Vol 26 (2) ◽  
pp. 157-163 ◽  
Author(s):  
Lakshmi Manogna Chintalacheruvu ◽  
Trudy Shaw ◽  
Avanija Buddam ◽  
Osama Diab ◽  
Thamer Kassim ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Genetic Testing ◽  
Gastrointestinal Cancer ◽  
Pigment Epithelium ◽  
Retinal Pigment ◽  
Clinical Manifestations ◽  
Micro Rna ◽  
Diffuse Gastric Cancer ◽  
Adenomatous Polyposis ◽  
Cancer Syndromes

Gastrointestinal cancer is one of the major causes of death worldwide. Hereditary gastrointestinal cancer syndromes constitute about 5-10% of all cancers. About 20-25% of undiagnosed cases have a possible hereditary component, which is not yet established. In the last few decades, the advance in genomics has led to the discovery of multiple cancer predisposition genes in gastrointestinal cancer. Physicians should be aware of these syndromes to identify high-risk patients and offer genetic testing to prevent cancer death. In this review, we describe clinical manifestations, genetic testing and its challenges, diagnosis and management of the major hereditary gastrointestinal cancer syndromes.Key words:  −  −  −  − .Abbreviations: ACG: American College of Gastroenterology; AFAP: attenuated FAP; APC: adenomatous polyposis coli; CDH1: E-cadherin; CHRPE: congenital hypertrophy of the retinal pigment epithelium; CRC: colorectal cancer; FAMMM: Familial atypical multiple mole melanoma; FAP: Familial adenomatous polyposis; GC: gastric cancer; HDGC: Hereditary diffuse gastric cancer; IHC: immunohistochemical; IPAA: ileal pouch–anal anastomosis; IRA: ileorectal anastomosis; MSI: microsatellite instability; MMR: mismatch repair; miRNA: micro RNA.

The feasibility of individualized prehabilitation for patients undergoing gastrointestinal cancer resections: a pilot study

2019 ◽  
Vol 74 (1) ◽  
Author(s):  
Juliane Bingener-Casey ◽  
Brent A. Bauer ◽  
Susanne M. Cutshall ◽  
Pamela E. Skaran ◽  
Andrea L. Cheville ◽  
...  
Keyword(s):  
Pilot Study ◽  
Gastrointestinal Cancer
Sign in / Sign up

Export Citation Format

Share Document